SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-011026
Filing Date
2022-03-18
Accepted
2022-03-18 14:06:35
Documents
74
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K inkt-10k_20211231.htm   iXBRL 10-K 2102326
2 EX-4.2 inkt-ex42_268.htm EX-4.2 22019
3 EX-10.16 inkt-ex1016_207.htm EX-10.16 125964
4 EX-10.17 inkt-ex1017_206.htm EX-10.17 182315
5 EX-21.1 inkt-ex211_205.htm EX-21.1 5110
6 EX-31.1 inkt-ex311_7.htm EX-31.1 20177
7 EX-31.2 inkt-ex312_8.htm EX-31.2 21974
8 EX-32.1 inkt-ex321_9.htm EX-32.1 9372
9 EX-32.2 inkt-ex322_6.htm EX-32.2 9282
10 GRAPHIC g4hu2k4m2rvw000001.jpg GRAPHIC 121637
11 GRAPHIC g4hu2k4m2rvw000003.jpg GRAPHIC 83139
12 GRAPHIC g4hu2k4m2rvw000004.jpg GRAPHIC 355705
13 GRAPHIC g4hu2k4m2rvw000002.jpg GRAPHIC 334044
  Complete submission text file 0001564590-22-011026.txt   8811135

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA inkt-20211231.xsd EX-101.SCH 39496
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inkt-20211231_cal.xml EX-101.CAL 41712
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inkt-20211231_def.xml EX-101.DEF 93082
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE inkt-20211231_lab.xml EX-101.LAB 340796
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inkt-20211231_pre.xml EX-101.PRE 249312
68 EXTRACTED XBRL INSTANCE DOCUMENT inkt-10k_20211231_htm.xml XML 789483
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40908 | Film No.: 22752011
SIC: 2836 Biological Products, (No Diagnostic Substances)